# Olaparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer and a BRCA1 and/or BRCA2 mutation: SOLO1 China cohort

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/olaparib-maintenance-therapy-in-patients-with-newly-diagnosed-advanced-ovarian/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Lingying Wu,Jianqing Zhu,Rutie Yin,Xiaohua Wu,Ge Lou,Jing Wang,Yunong Gao,Beihua Kong,Xin Lu,Qi Zhou,Yueling Wang,Youguo Chen,Weiguo Lü,Wei Li,Ying Cheng,Jihong Liu,Xin Ma,Jing Zhang |
| Citations | 45 |
| DOI | 10.1016/j.ygyno.2020.10.005 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3141293352 |
| PMID | 33250205 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Weiguo Lü](https://scholariq.org/researchers/weiguo-lu/)
- [Qi Zhou](https://scholariq.org/researchers/qi-zhou/)
- [Beihua Kong](https://scholariq.org/researchers/beihua-kong/)
- [Ying Cheng](https://scholariq.org/researchers/ying-cheng/)
- [Jihong Liu](https://scholariq.org/researchers/jihong-liu/)

## Paper funders

- [AstraZeneca](https://scholariq.org/funders/astrazeneca/)

## Paper journal

- [Gynecologic Oncology](https://scholariq.org/journals/gynecologic-oncology/)

## Paper primary topic

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

## Paper topics

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [BRCA gene mutations in cancer](https://scholariq.org/topics/brca-gene-mutations-in-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.